Thymosin alpha-1 immunotherapy restored immune homeostasis (CD4/CD8 ratio, HLA-DR expression) and increased survival in septic patients — clinical evidence for peptide immunotherapy in the most lethal infectious condition.
Key findingThymosin alpha-1 immunotherapy restored immune homeostasis (CD4/CD8 ratio, HLA-DR expression) and increased survival in septic patients — clinical evi
What the researchers found
Thymosin alpha-1 immunotherapy restored immune homeostasis (CD4/CD8 ratio, HLA-DR expression) and increased survival in septic patients — clinical evidence for peptide immunotherapy in the most lethal infectious condition.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Immunotherapy improves immune homeostasis and increases survival rate of septic patients.
Chinese journal of traumatology = Zhonghua chuang shang za zhi, 12(6), 344-9
Citation
Huang, Shun-wei; Chen, Juan; Ouyang, Bin; Yang, Chun-hua; Chen, Min-ying; Guan, Xiang-dong. (2009). Immunotherapy improves immune homeostasis and increases survival rate of septic patients.. Chinese journal of traumatology = Zhonghua chuang shang za zhi, 12(6), 344-9.